CN1943602A - Bee pollen bee glue composition and its preparing method - Google Patents
Bee pollen bee glue composition and its preparing method Download PDFInfo
- Publication number
- CN1943602A CN1943602A CNA2006100538664A CN200610053866A CN1943602A CN 1943602 A CN1943602 A CN 1943602A CN A2006100538664 A CNA2006100538664 A CN A2006100538664A CN 200610053866 A CN200610053866 A CN 200610053866A CN 1943602 A CN1943602 A CN 1943602A
- Authority
- CN
- China
- Prior art keywords
- bee
- pollen
- propolis
- bee pollen
- glue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940038481 bee pollen Drugs 0.000 title claims abstract description 41
- 239000003292 glue Substances 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims description 20
- 238000000034 method Methods 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 241000241413 Propolis Species 0.000 claims description 46
- 229940069949 propolis Drugs 0.000 claims description 46
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 abstract description 14
- 239000011812 mixed powder Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000013543 active substance Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000004223 radioprotective effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- -1 terpene compound Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Jellies, Jams, And Syrups (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a compound of bee pollen and glue, comprising according to percent by weight : bee glue 70-30%, bee pollen 30-70% . The bee glue used in said invention is extracted by alcohol as pure glue and pollen as the wall-broken one. Compound of been glue and pollen provided in said invention is making powder of pollen and half of glue powder mixed evenly, thereafter mixing compound obtained with the other half left glue powder, screening through 80 mesh and mixing fully, packing the mixed powder into capsule by hand or machine to obtain said compound in the invention.
Description
Technical field
The present invention relates to a kind of biological health food, exactly is a kind of bee pollen bee glue composition and preparation method.
Background technology
The propolis resin that to be Apis gather from positions such as the tree bud of plant, barks, mix glandular secretion things such as lingual gland with Apis, wax gland, a kind of colloid substance that is transformed through Apis processing.The propolis complicated component, be rich in flavonoid, phenolic acids, terpene compound, trace element, multivitamin etc., effect with enhancing human body immunity function, antioxidation, promotion tissue regeneration, anti-inflammation, blood sugar lowering blood fat, clinically hyperglycemia, hypertension, hyperlipidemia there are remarkable auxiliary curative effect, remarkable effect are also arranged for antioxidation, slow down aging.Because the effect of the brilliance of propolis, existing now many bee glue products comprise some bee glue capsule products.
Pure propolis powder very easily condenses, and is mobile poor, is difficult to filled capsules, even after being packed into capsule, the in bulk that also very easily condenses is unfavorable for that gastrointestinal absorbs.Therefore no matter being pure bee glue capsule product, still is the capsule product that batching is made with the propolis, all needs to add filler in the capsule course of processing, to increase the flowability of capsule 's content, prevent that the propolis granule is inter-adhesive, the propolis granule can effectively be disassembled in gastrointestinal tract, improve absorbance.Filler commonly used at present has starch, lactose and maltodextrin etc.These filleies have occupied the limited space of capsule, and human body is not but had any health-care effect, make active substance content step-down in the capsule, are unfavorable for giving full play to the health-care effect of bee glue powder capsule.
Summary of the invention
The purpose of this invention is to provide a kind of bee pollen bee glue composition, by percentage by weight be: propolis 70～30%, bee pollen 30～70% are formed.
The used propolis of the present invention is the pure propolis of ethanol extraction, and bee pollen is a broker wall bee pollen.
Another object of the present invention provides the preparation method of bee pollen bee glue composition, be earlier with behind bee pollen powder and the propolis powder mix homogeneously of half, again with this mixture and remaining half propolis powder mixing, cross 80 orders, fully stir, utilize hand-stuff or machine is filled and made after mixed-powder incapsulated.
Bee pollen is an Apis herborization pollen, the mixed particulate matter that forms with some secretions of self, the protein, lipid, carbohydrate, various vitamin and the trace element that contain needed by human, also contain the multiple bioactive substance such as flavonoid, nucleic acid, natural phytohormone that function of human body is had special efficacy, be described as " miniature nutrition library ".Wherein rich nutrient contents not only can provide human body various nutritional labelings, for the growth and the reparation of body tissue cell provides abundant raw material, simultaneously, the physiological function of nutritional labeling in the bee pollen and biological active matter confrontation body, the physiological activity of each tract all has regulating action in various degree.Therefore, bee pollen has effects such as blood fat reducing, radioprotective, defying age, anti-hypoxia, enhance immunity, looks improving and the skin nourishing.
The present invention uses bee pollen to replace conventional filler, can make full use of capsular space, has the bee pollen bee glue capsule that high health care is worth.Because propolis powder and broker wall bee pollen powder are fully mixed, capsule product involved in the present invention has following characteristics:
1, compositions provided by the invention not only has the various health-care effects of propolis, can remove too much free radical in the body effectively, strengthens immune function of human body, blood viscosity lowering, prevent and delay arteriosclerosis, but also have the various effects of bee pollen, as radioprotective, looks improving and the skin nourishing etc.Bee pollen and propolis complement each other, and synergism makes this product have more the good health care effect.Especially has better effect aspect blood fat reducing, antioxidation, defying age, the looks improving and the skin nourishing;
2, because bee pollen is distributed between the propolis granule, thereby treat capsule in gastrointestinal tract after the disintegrate, its content can effectively and quickly scatter under the effect of Digestive system, helps absorption of human body;
3, compositions provided by the invention is in storage process, and propolis can play a protective role to bee pollen, can delay or avoid the loss of active substance in the bee pollen.
The specific embodiment
The present invention is further described by the specific embodiment.
Embodiment 1
The invention provides a kind of bee pollen bee glue composition, by percentage by weight be: propolis 70～30%, bee pollen 30～70% are formed.For example, propolis 60%, bee pollen 40%, or propolis 50%, bee pollen 50%, or propolis 40%, bee pollen 60%, or propolis 70, pollen 30, or the proportioning of propolis 30, pollen 70 all can obtain good effect.Used propolis is the pure propolis of ethanol extraction, and bee pollen is a broker wall bee pollen.
Embodiment 2
A kind of preparation method of bee pollen bee glue composition, be first,, cross 80 orders again with this mixture and remaining half propolis powder mixing with behind bee pollen powder and the propolis powder mix homogeneously of half, fully stir, utilize hand-stuff or machine is filled and made after mixed-powder incapsulated.
Embodiment 3
The comparative experiments research of product of the present invention and conventional products effect for reducing blood fat.
Diabetes SD rat is divided into 4 groups at random, 15 every group, is respectively model group, conventional propolis group (60% propolis adds 40% starch), pollen propolis 1 group of (40% propolis adds 60% bee pollen) and 2 groups of pollen propolis (60% propolis adds 40% bee pollen).Other gets 15 and is normal group.Except that normal group, all the other 4 groups of high lipid foods of feeding.The result shows, after 6 weeks of administration, with model group relatively, conventional propolis group serum cholesterol and content of triglyceride obviously descend (P＜0.05); Pollen propolis mixture then can extremely significantly suppress serum cholesterol and triglyceride and raise (P＜0.01), illustrates that bee pollen replaces starch to have obvious superiority as filler.The situation of change in hyperglycemia hyperlipidemia SD rat blood serum cholesterol (TC) and triglyceride (TG) 6 weeks of content sees Table 1 and table 2 respectively.
The situation of change in table 1 hyperglycemia hyperlipidemia SD rat blood serum cholesterol (TC) 6 weeks of content (x ± s)
| Group | The 0th week | The 2nd week | The 4th week | The 6th week | ||||
| n | TC | n | TC | n | TC | n | TC | |
| Normally | 15 | 2.05±0.18 | 15 | 2.23±0.22 | 15 | 2.45±0.18 | 15 | 2.54±0.19 |
| Model | 15 | 2.02±0.16 | 14 | 11.00±1.45 | 13 | 11.46±1.18 | 13 | 11.28±1.56 |
| Propolis | 15 | 1.99±0.17 | 13 | 10.50±1.32 | 13 | 10.15±1.02 | 12 | 9.78±1.12* |
| Propolis pollen 1 | 15 | 2.00±0.16 | 15 | 10.46±1.26 | 15 | 9.75±1.20* | 14 | 9.02±1.75** |
| Propolis pollen 2 | 15 | 2.01±0.15 | 15 | 10.45±1.23 | 15 | 9.26±1.09** | 14 | 8.25±1.15** |
The situation of change in table 2 hyperglycemia hyperlipidemia SD rat blood serum triglyceride (TG) 6 weeks of content (x ± s)
| Group | The 0th week | The 2nd week | The 4th week | The 6th week | ||||
| n | TG | n | TG | n | TG | n | TG | |
| Normally | 15 | 1.43±0.12 | 15 | 1.53±0.20 | 15 | 1.46±0.19 | 15 | 1.65±0.15 |
| Model | 15 | 1.50±0.17 | 14 | 8.09±1.39 | 13 | 8.46±1.28 | 13 | 9.65±1.38 |
| Propolis | 15 | 1.56±0.18 | 13 | 7.65±1.22 | 13 | 7.60±1.19* | 12 | 8.10±1.46* |
| Propolis pollen 1 | 15 | 1.47±0.17 | 15 | 8.25±1.32 | 15 | 6.60±1.21** | 14 | 7.39±1.92** |
| Propolis pollen 2 | 15 | 1.46±0.25 | 15 | 7.28±1.13 | 15 | 6.57±1.19** | 14 | 7.25±1.35** |
Annotate: " * " represents P＜0.05, and " * * " represents P＜0.01.
Claims (3)
1. a bee pollen bee glue composition is characterized in that: be made up of 30～70% propolis and 70～30% bee pollen.
2. a kind of bee pollen bee glue composition according to claim 1 is characterized in that: used propolis is the pure propolis of ethanol extraction, and bee pollen is a broker wall bee pollen.
3. the preparation method of a kind of bee pollen bee glue composition according to claim 1, it is characterized in that: earlier with behind bee pollen powder and the propolis powder mix homogeneously of half, with this mixture and remaining half propolis powder mixing, fully stir again, make after incapsulating.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2006100538664A CN1943602A (en) | 2006-10-17 | 2006-10-17 | Bee pollen bee glue composition and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2006100538664A CN1943602A (en) | 2006-10-17 | 2006-10-17 | Bee pollen bee glue composition and its preparing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1943602A true CN1943602A (en) | 2007-04-11 |
Family
ID=38043396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2006100538664A Pending CN1943602A (en) | 2006-10-17 | 2006-10-17 | Bee pollen bee glue composition and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1943602A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102132810A (en) * | 2011-03-14 | 2011-07-27 | 白万军 | VC composite propolis capsule health-care food |
| CN102150771A (en) * | 2011-03-18 | 2011-08-17 | 杭州碧于天保健品有限公司 | Anti-radiation bee product composite preparation and preparation method thereof |
| WO2013166766A1 (en) * | 2012-05-09 | 2013-11-14 | 百正药业股份有限公司 | Repair agent for skin inflammation caused by computer and mobile phone radiation |
| CN103494050A (en) * | 2013-09-26 | 2014-01-08 | 张路扬 | Novel formula and production technology of propolis tablet product |
| CN106617049A (en) * | 2016-09-29 | 2017-05-10 | 广州市汇吉科技企业孵化器有限公司 | Propolis healthcare product with moringa oleifera leaf extract and method for preparing propolis healthcare product |
| CN109170865A (en) * | 2018-09-30 | 2019-01-11 | 湖北天夏生物工程有限公司 | A kind of health care product and preparation method thereof adjusting immunity |
-
2006
- 2006-10-17 CN CNA2006100538664A patent/CN1943602A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102132810A (en) * | 2011-03-14 | 2011-07-27 | 白万军 | VC composite propolis capsule health-care food |
| CN102150771A (en) * | 2011-03-18 | 2011-08-17 | 杭州碧于天保健品有限公司 | Anti-radiation bee product composite preparation and preparation method thereof |
| WO2013166766A1 (en) * | 2012-05-09 | 2013-11-14 | 百正药业股份有限公司 | Repair agent for skin inflammation caused by computer and mobile phone radiation |
| CN103494050A (en) * | 2013-09-26 | 2014-01-08 | 张路扬 | Novel formula and production technology of propolis tablet product |
| CN106617049A (en) * | 2016-09-29 | 2017-05-10 | 广州市汇吉科技企业孵化器有限公司 | Propolis healthcare product with moringa oleifera leaf extract and method for preparing propolis healthcare product |
| CN109170865A (en) * | 2018-09-30 | 2019-01-11 | 湖北天夏生物工程有限公司 | A kind of health care product and preparation method thereof adjusting immunity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102283386B (en) | Composite camellia oil health care product with function of reducing blood fat and preparation method thereof | |
| JP6205616B2 (en) | Beautiful skin promoter and its use | |
| CN101053409A (en) | Health care food containing natural astaxanthin | |
| DE112005000488T5 (en) | Artificial fruits | |
| CN1943602A (en) | Bee pollen bee glue composition and its preparing method | |
| NO339322B1 (en) | Formulations containing cynara scolymus and phaseolus vulgaris extracts useful in the treatment of obesity | |
| CN101695324B (en) | Method for manufacturing fat lowering tea capable of adjusting blood fat | |
| CN1883308A (en) | Food | |
| CN112189839A (en) | Composition for assisting in reducing blood fat and application thereof | |
| Sharma et al. | Utilization of waste from tropical fruits | |
| CN105166620A (en) | Horseradish tree composition capable of reducing blood lipid and preparation method of horseradish tree composition | |
| CN104523829B (en) | A kind of propolis Radix Salviae Miltiorrhizae health food | |
| CN1298647A (en) | Health-care oil for regulating blood fat | |
| WO2014134834A1 (en) | Composition and food comprising same and preparation method of food | |
| CN1255050C (en) | Health care food and its making method | |
| CN1145236A (en) | Brain-care foods or medicine and its prodn. method | |
| CN1274244C (en) | Nutrition health food and preparation method | |
| CN1141934C (en) | Health-care oil for regulating blood fat | |
| CN1303904C (en) | Olive calcium tablet | |
| CN105831730A (en) | Krill oil composite special dietary food for reducing hypertension, hyperglycemia and hyperlipidemia | |
| RU2616399C1 (en) | Method for producing biologically active product for adaptive feeding and biologically active product for adaptive feeding | |
| CN1899107A (en) | Health food recipe using shallot bulb as main material and processing method | |
| WO2018226192A2 (en) | Use of a herbal formulation containing linseed oil on those who cannot use fish oil, particularly on vegetarians as a herbal omega 3 (ala) source | |
| CN115153035A (en) | Dietary fiber composite protein powder for diabetic patients | |
| CN1406627A (en) | Superfine powder of Tangniaokang against diabetic and preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |